Clinical trials
Recruiting Phase 1/2 trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
190 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 14 |
| 2022 | 20 |
| 2023 | 26 |
| 2024 | 29 |
| 2025 | 55 |
| 2026 | 26 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 190 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 16 |
| Merck Sharp & Dohme LLC | 14 |
| Regeneron Pharmaceuticals | 8 |
| BioNTech SE | 6 |
| Bristol-Myers Squibb | 6 |
| GlaxoSmithKline | 5 |
| Institute of Cancer Research, United Kingdom | 5 |
| Novartis Pharmaceuticals | 5 |
| BeOne Medicines | 4 |
| Cancer Research UK | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 18 |
| Neoplasms | 18 |
| Colorectal Neoplasms | 14 |
| Breast Neoplasms | 12 |
| Ovarian Neoplasms | 12 |
| Prostatic Neoplasms | 12 |
| Multiple Myeloma | 11 |
| Recurrence | 10 |
| Lymphoma, Non-Hodgkin | 9 |
| Neoplasm Metastasis | 9 |
Trials
Showing 1 to 25 of 190. Each trial links to its page on Pharma Observatory.
90 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.